Veradigm | MDRX - Interest Expense On Debt


Veradigm reported $1.25M in Interest Expense on Debt for its fiscal quarter ending in September of 2022.





Interest Expense On Debt Change Date
Alcidion AUD 32K 9K Dec/2025
Ambu A/S DKK 19M 4M Mar/2026
Amplifon EUR 13.87M 155K Mar/2026
Cardinal Health USD 101M 13M Mar/2026
Centene USD 164M 4M Mar/2026
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Cigna USD 153.27B 4.65B Mar/2026
Coloplast 164M 0 Dec/2025
Computer Programs Systems USD 2.87M 911K Dec/2025
CVS Health USD 774M 13M Mar/2026
Diasorin EUR 5M 0 Mar/2026
Elevance Health USD 357M 9M Mar/2026
General Electric Aerospace USD 496M 271M Dec/2025
Gulf Medical Proj AED 33K 9K Sep/2024
Humana USD 193M 47M Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Laboratory Of America USD 55.1M 100K Mar/2026
Maximus USD 22.11M 1.3M Mar/2026
McKesson USD 63M 11M Dec/2025
Med Life RON 24.78M 2.15M Dec/2023
Molina Healthcare USD 54M 2M Mar/2026
Omnicell USD 431K 91K Dec/2025
Oriola-kd EUR 1.4M 600K Mar/2026
Owens Minor USD 27.93M 1.1M Dec/2025
Quest Diagnostics USD 69M 2M Sep/2025
Rede D'or Sao Luiz BRL 1.5B 2.05B Dec/2025
Siemens Healthineers EUR 100M 4M Mar/2026
Sonova Holding CHF 24.2M 3.7M Jun/2025
Supermax Corporation Bhd MYR 1.66M 1.44M Sep/2025
UnitedHealth USD 955M 19M Mar/2026
Veeva Systems USD 65.1M 8.4M Mar/2025
Veradigm USD 1.25M 641K Sep/2022
Xerox USD 31M 0 Dec/2024